China's EpimAb Hunts For Novel Biologics With Funding, Partnerships

Dr. Wu Chengbin, CEO and founder of Shanghai-based EpimAb Biotherapeutics, discusses with Scrip’s Brian Yang how the startup's platform will help companies develop next-generation bispecific antibodies.